ArticleFrontiers in oncology2025
Development and validation of an LDCT-based deep learning radiomics nomogram for predicting postoperative recurrence of stage Ia lung adenocarcinoma.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A methodological framework for integrating generalisable deep learning and radiomics fusion model for early lung cancer detection across multi-centre imaging datasets.BMC medical informatics and decision making · 2026Pooled it
- Significant improvement in overall survival with postoperative traditional Chinese medicine in stage I lung adenocarcinoma: a real-world retrospective cohort study.Translational lung cancer research · 2026Article
- Artificial intelligence in thoracic surgery: a narrative review of clinical advances and applications in 2025.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study wanted to use low-dose computed tomography (LDCT) plain scan images to create a deep learning radiomic nomogram (DLRN) to accurately predict the likelihood of recurrence after surgery in patients with stage Ia lung adenocarcinoma (LUAD). Methods: We collected cases from January 2010 to December 2020 at Center 1 who underwent surgery and were pathologically diagnosed with stage Ia LUAD, and additionally collected patients with the same criteria at Center 2 from January 2015 to December 2018 for external validation. Deep learning and radiomic feature extraction were performed on LDCT images of all patients. In the deep learning and radiomics methods, we tested multiple different models and selected the best model based on the results of the internal validation cohort. Finally, we construct a nomogram by combining deep learning features, radiomics features and clinical data. Subsequently, We used the receiver operating characteristic (ROC) curve to check how well these models performed in terms of diagnosis. The calibration degree of each model was evaluated using calibration curves, while the clinical value of each model was assessed through decision curve analysis (DCA). Results: In Center 1, we collected a total of 233 eligible patients, who were randomly divided into a training cohort (163 patients) and an internal validation cohort (70 patients) at a 7:3 ratio. And we collected included a total of 89 patients in Center 2. Internal validation results showed Resnet50 and Logistic Regression (LR) as optimal models for deep learning and radiomics approaches, respectively. The area under the curve (AUC) values for this combined model were 0.972 (95% CI: 0.949-0.995) in the training cohort, 0.925 (95% CI: 0.845-1.000) in the internal validation cohort, and 0.915 (95% CI: 0.853-0.976) in the external validation cohort. Compared with other single models, it demonstrated the best performance. Conclusion: Preoperative DLRN based on LDCT plain scan images exhibit good predictive value for postoperative recurrence in patients with stage Ia LUAD. The present study developed a novel prognostic assessment method with the objective of assisting clinicians in refining adjuvant treatment plans for patients with stage Ia LUAD, thus facilitating personalised prognostic management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.